PRKCA and neoplasm: CA inhibits the migration and invasive capacity of tumor cells, modulates mTOR2-related pathways, and reduces the phosphorylation of p-protein kinase C alpha (PKCα), Akt, along with declined expression of Rictor and F-actin (factors responsible for cell growth and organization of actin cytoskeleton).